Arthur Henderson News
-
Health-care providers are unlikely to sustain a stock-market lead over medical plans once the U.S. Supreme Court decides on the Patient Protection and Affordable Care Act, according to Jefferies & Co. analysts.
-
HCA Holdings Inc.’s report of a drop in expensive surgeries may signal a broad slowdown for hospitals because of rising unemployment and tepid consumer spending.
-
Emergency Medical Services Corp. is near an agreement to be acquired by private-equity firm Clayton Dubilier & Rice LLC in a leveraged buyout valued at about $3.1 billion, three people familiar with the matter said.
-
Hospital operators such as Tenet Healthcare Corp. will get higher federal payments for emergency room visits, diagnostic imaging and other outpatient services in 2012 under U.S. rules.
-
Kindred Healthcare Inc. ’s purchase of RehabCare Group Inc. may signal more acquisitions as health-care providers aim to expand services in response to government efforts to reduce costs.
-
Medco Health Solutions Inc., the drug-benefits manager seeking to merge with rival Express Scripts Inc., said third-quarter profit beat analysts’ estimates on greater use of generic drugs. The shares rose 11 percent.
-
Medco Health Solutions Inc. , the largest U.S. prescription benefits manager, fell the most in seven months in New York trading on concern that profit growth isn’t accelerating.
-
HCA Holdings Inc. and Tenet Healthcare Corp. led hospital stocks higher after the companies said a settlement of a 13-year-old lawsuit over Medicare payments would boost revenue and HCA reported higher admissions.
-
Medco Health Solutions Inc. fell the most in almost six months after Reuters reported that “key people” at the U.S. Federal Trade Commission are seeking to stop the company’s proposed $29.1 billion acquisition by rival pharmacy benefits company Express Scripts Inc.
-
Emergency Medical Services Corp. shares fell the most in almost two years after the company agreed to be bought by private-equity firm Clayton, Dubilier & Rice LLC for $64 a share, less than some investors expected.
|
|
Most Popular on Bloomberg
|
| |